10zyme

10zyme is an early-stage medical technology company developing a point-of-care self-test for high-risk human papillomavirus, integrating synthetic biology with machine learning to deliver instant results without laboratory processing.

Its test screens for all 14 high-risk HPV types linked to cervical cancer, addressing a key limitation of existing self-collection methods that still require centralised laboratory analysis.

The technology targets women who disengage from traditional clinical screening settings.